Lewy Body Dementia (LBD) Latest Advances

Find the Latest Research About Lewy Body Dementia (LBD)

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5757 publications

From General-Purpose to Disease-Specific Features: Aligning LLM Embeddings on a Disease-Specific Biomedical Knowledge Graph for Drug Repurposing.

From General-Purpose to Disease-Specific Features: Aligning LLM Embeddings on a Disease-Specific Biomedical Knowledge Graph for Drug Repurposing.

Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026

Resting-State EEG Features of Cognitive Fluctuations Across the Lewy Body Disease Spectrum.

Resting-State EEG Features of Cognitive Fluctuations Across the Lewy Body Disease Spectrum.

Journal: Research square
Published: April 10, 2026

Cross-disease genetic and epigenetic architecture of the MOBP locus shows convergence in ALS-PSP.

Cross-disease genetic and epigenetic architecture of the MOBP locus shows convergence in ALS-PSP.

Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026

Pathology and genetics in a global cohort of Parkinsonian Disorders.

Pathology and genetics in a global cohort of Parkinsonian Disorders.

Journal: medRxiv : the preprint server for health sciences
Published: April 03, 2026

Brain-Only Versus GI-Only Synucleinopathy: A Comprehensive Autopsy Study With Both IHC and SAA.

Brain-Only Versus GI-Only Synucleinopathy: A Comprehensive Autopsy Study With Both IHC and SAA.

Journal: medRxiv : the preprint server for health sciences
Published: April 03, 2026

Patients' and care partners' views on communicating the cause of dementia and related uncertainties: A qualitative study.

Patients' and care partners' views on communicating the cause of dementia and related uncertainties: A qualitative study.

Journal: Journal of Alzheimer's disease : JAD
Published: April 03, 2026

Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease.

Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease.

Journal: medRxiv : the preprint server for health sciences
Published: April 03, 2026

Dementia in Severe Schizophrenia.

Dementia in Severe Schizophrenia.

Journal: JAMA psychiatry
Published: April 01, 2026

Affective neuropsychiatric symptom metrics in the National Alzheimer's Coordinating Center dataset.

Affective neuropsychiatric symptom metrics in the National Alzheimer's Coordinating Center dataset.

Journal: Journal of Alzheimer's disease : JAD
Published: March 25, 2026

Fluid Biomarkers of Motor and Non-Motor Experiences of Daily Living in Dementia with Lewy Bodies and Alzheimer's Disease.

Fluid Biomarkers of Motor and Non-Motor Experiences of Daily Living in Dementia with Lewy Bodies and Alzheimer's Disease.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: March 25, 2026

The performance of plasma pTau181 and pTau217 in distinguishing Alzheimer's disease from various neurodegenerative disorders, psychiatric disorders, and cognitively unimpaired controls.

The performance of plasma pTau181 and pTau217 in distinguishing Alzheimer's disease from various neurodegenerative disorders, psychiatric disorders, and cognitively unimpaired controls.

Journal: Journal of Alzheimer's disease : JAD
Published: March 23, 2026

DYNAMIC CLASSIFICATION OF LATENT DISEASE PROGRESSION WITH AUXILIARY SURROGATE LABELS.

DYNAMIC CLASSIFICATION OF LATENT DISEASE PROGRESSION WITH AUXILIARY SURROGATE LABELS.

Journal: The annals of applied statistics
Published: March 23, 2026
Showing 1-12 of 5,757

Last Updated: 04/28/2026